Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 16, 2021 03:00 ET | Source: KetamineOne Capital Limited

Ketamine One Subsidiary IRP Health Opens Two New Veteran-Focused Clinics

VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: 6FC), a company focused on...
November 15, 2021 18:00 ET | Source: KetamineOne Capital Limited

Ketamine One Provides Update on Management Cease Trade Order

VANCOUVER, British Columbia, Nov. 15, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: 6FC), a company focused on consolidating...
November 09, 2021 03:00 ET | Source: KetamineOne Capital Limited

Ketamine One Announces Intention to Submit Draft Registration Statement for Proposed U.S. Initial Public Offering

Director Steven Inglefield Has Also Been Appointed Chief Operating Officer of the Company VANCOUVER, British Columbia, Nov. 09, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One”...
November 04, 2021 18:00 ET | Source: KetamineOne Capital Limited

Ketamine One Announces Resignation of Loreto Grimaldi From Board of Directors

VANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: 6FC), a company focused on consolidating...
November 04, 2021 03:00 ET | Source: KetamineOne Capital Limited

Ketamine One Announces Virtual Mental Healthcare Platform in Partnership With iHealthOX

VANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: 6FC), a company focused on consolidating...
November 01, 2021 19:05 ET | Source: KetamineOne Capital Limited

Ketamine One Announces Late Filing of Annual Financial Statements and Management Cease Trade Order

VANCOUVER, British Columbia, Nov. 01, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: 6FC), a company focused on...
October 21, 2021 18:05 ET | Source: KetamineOne Capital Limited

Ketamine One Provides Updated Information for Stock Exchange Listings

VANCOUVER, British Columbia, Oct. 21, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: 6FC), a company focused on...
October 20, 2021 03:00 ET | Source: KetamineOne Capital Limited

Ketamine One Features Biostrap as Part of Inaugural Research Studies

VANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
October 14, 2021 03:00 ET | Source: KetamineOne Capital Limited

Ketamine One Launching Two Inaugural Research Studies

VANCOUVER, British Columbia, Oct. 14, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...
October 06, 2021 03:00 ET | Source: KetamineOne Capital Limited

Ketamine One Subsidiary KGK Science Contracted to Support a Ketamine Clinical Trial in the United States

VANCOUVER, British Columbia, Oct. 06, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on...